Open AccessOutcomes after Usage of Ponto Implant System
Author(s) -
Babu Seilesh,
McKin Brian J.,
Fucci Michael J.
Publication year - 2012
Publication title -
otolaryngology–head and neck surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.232
H-Index - 121
eISSN - 1097-6817
pISSN - 0194-5998
DOI - 10.1177/0194599812451438a171
Subject(s) - medicine , body mass index , implant , diabetes mellitus , sensorineural deafness , hearing loss , surgery , audiology , endocrinology
Objective Bone‐anchored hearing systems have proven to be an effective amplification solution for conductive, mixed, and profound unilateral sensorineural hearing losses. The Ponto bone‐anchored hearing system has been available in the United States for 2 years. Method This multicenter study was performed to review our experience with the Ponto system in 99 patients from 3 medical centers. The mean follow‐up was 6 months and the average loading time was 80 days. The linear surgical technique was used in 95% of cases. Clinical outcomes were measured. Results Of the 99 cases, there were no implant losses. Factors such as gender, hypertension, diabetes, body mass index (BMI), and smoking were investigated to determine any correlation between skin reactions that were found. Smoking was the only factor to be found significant in correlating to skin reactions ( P <. 05). Conclusion The Ponto bone‐anchored hearing system is an effective and successful treatment option for conductive and single sided deafness. Factors were evaluated to determine skin reactions and implant survival. These include gender, hypertension, diabetes, tobacco usage, and BMI. Only tobacco usage seemed to be a significant factor in skin reactions.